Dose, duration, and cost: opportunities to improve use of long-term oral antibiotics for people with rosacea

Joanne S. Rill, Hadar Lev-Tov, Guodong Liu, Joslyn Sciacca Kirby

Research output: Contribution to journalArticle

Abstract

Background: Systemic antibiotics are often used to treat rosacea and tetracyclines are the most common antibiotic prescribed; however, there is ambiguity among clinical guideline suggestions. Importantly, there is an increasing call to all clinicians to curtail antibiotic use. Objective: To investigate the utilization and cost of long-term oral antibiotic use for the treatment of rosacea, including ocular rosacea. Methods: This was a retrospective cohort study of MarketScan ® Commercial Claims and Encounters database, from January 1, 2005 through December 31, 2014. Claim data were used to determine the duration and costs of antibiotic treatment among adults with rosacea. Results: The sample included 72,411 patients. The mean (SD) duration of long-term antibiotic treatment was 87.68 (145.99) days and for patients with ocular rosacea was slightly longer, 108.34 (176.74) days [p <.0001]. The majority of antibiotic courses were shorter than 3 months (80.04%) for the entire sample and the subset with ocular rosacea (53.64% [p =.007]). Limitations: Patient adherence is uncertain and database lacks information on rosacea severity and clinical outcomes. Conclusions: The majority of oral antibiotic course durations follow guidelines. Costs of antibiotic therapy were lower for shorter courses and those utilizing generic medications; the cost-effectiveness of these modifications has not been investigated.

Original languageEnglish (US)
Pages (from-to)63-67
Number of pages5
JournalJournal of Dermatological Treatment
Volume30
Issue number1
DOIs
StatePublished - Jan 2 2019

Fingerprint

Rosacea
Anti-Bacterial Agents
Costs and Cost Analysis
Databases
Guidelines
Tetracyclines
Patient Compliance
Health Care Costs
Cost-Benefit Analysis
Cohort Studies
Therapeutics
Retrospective Studies

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

@article{7d6058b4d182405882df751d308116af,
title = "Dose, duration, and cost: opportunities to improve use of long-term oral antibiotics for people with rosacea",
abstract = "Background: Systemic antibiotics are often used to treat rosacea and tetracyclines are the most common antibiotic prescribed; however, there is ambiguity among clinical guideline suggestions. Importantly, there is an increasing call to all clinicians to curtail antibiotic use. Objective: To investigate the utilization and cost of long-term oral antibiotic use for the treatment of rosacea, including ocular rosacea. Methods: This was a retrospective cohort study of MarketScan {\circledR} Commercial Claims and Encounters database, from January 1, 2005 through December 31, 2014. Claim data were used to determine the duration and costs of antibiotic treatment among adults with rosacea. Results: The sample included 72,411 patients. The mean (SD) duration of long-term antibiotic treatment was 87.68 (145.99) days and for patients with ocular rosacea was slightly longer, 108.34 (176.74) days [p <.0001]. The majority of antibiotic courses were shorter than 3 months (80.04{\%}) for the entire sample and the subset with ocular rosacea (53.64{\%} [p =.007]). Limitations: Patient adherence is uncertain and database lacks information on rosacea severity and clinical outcomes. Conclusions: The majority of oral antibiotic course durations follow guidelines. Costs of antibiotic therapy were lower for shorter courses and those utilizing generic medications; the cost-effectiveness of these modifications has not been investigated.",
author = "Rill, {Joanne S.} and Hadar Lev-Tov and Guodong Liu and {Sciacca Kirby}, Joslyn",
year = "2019",
month = "1",
day = "2",
doi = "10.1080/09546634.2018.1468069",
language = "English (US)",
volume = "30",
pages = "63--67",
journal = "Journal of Dermatological Treatment",
issn = "0954-6634",
publisher = "Informa Healthcare",
number = "1",

}

Dose, duration, and cost : opportunities to improve use of long-term oral antibiotics for people with rosacea. / Rill, Joanne S.; Lev-Tov, Hadar; Liu, Guodong; Sciacca Kirby, Joslyn.

In: Journal of Dermatological Treatment, Vol. 30, No. 1, 02.01.2019, p. 63-67.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Dose, duration, and cost

T2 - opportunities to improve use of long-term oral antibiotics for people with rosacea

AU - Rill, Joanne S.

AU - Lev-Tov, Hadar

AU - Liu, Guodong

AU - Sciacca Kirby, Joslyn

PY - 2019/1/2

Y1 - 2019/1/2

N2 - Background: Systemic antibiotics are often used to treat rosacea and tetracyclines are the most common antibiotic prescribed; however, there is ambiguity among clinical guideline suggestions. Importantly, there is an increasing call to all clinicians to curtail antibiotic use. Objective: To investigate the utilization and cost of long-term oral antibiotic use for the treatment of rosacea, including ocular rosacea. Methods: This was a retrospective cohort study of MarketScan ® Commercial Claims and Encounters database, from January 1, 2005 through December 31, 2014. Claim data were used to determine the duration and costs of antibiotic treatment among adults with rosacea. Results: The sample included 72,411 patients. The mean (SD) duration of long-term antibiotic treatment was 87.68 (145.99) days and for patients with ocular rosacea was slightly longer, 108.34 (176.74) days [p <.0001]. The majority of antibiotic courses were shorter than 3 months (80.04%) for the entire sample and the subset with ocular rosacea (53.64% [p =.007]). Limitations: Patient adherence is uncertain and database lacks information on rosacea severity and clinical outcomes. Conclusions: The majority of oral antibiotic course durations follow guidelines. Costs of antibiotic therapy were lower for shorter courses and those utilizing generic medications; the cost-effectiveness of these modifications has not been investigated.

AB - Background: Systemic antibiotics are often used to treat rosacea and tetracyclines are the most common antibiotic prescribed; however, there is ambiguity among clinical guideline suggestions. Importantly, there is an increasing call to all clinicians to curtail antibiotic use. Objective: To investigate the utilization and cost of long-term oral antibiotic use for the treatment of rosacea, including ocular rosacea. Methods: This was a retrospective cohort study of MarketScan ® Commercial Claims and Encounters database, from January 1, 2005 through December 31, 2014. Claim data were used to determine the duration and costs of antibiotic treatment among adults with rosacea. Results: The sample included 72,411 patients. The mean (SD) duration of long-term antibiotic treatment was 87.68 (145.99) days and for patients with ocular rosacea was slightly longer, 108.34 (176.74) days [p <.0001]. The majority of antibiotic courses were shorter than 3 months (80.04%) for the entire sample and the subset with ocular rosacea (53.64% [p =.007]). Limitations: Patient adherence is uncertain and database lacks information on rosacea severity and clinical outcomes. Conclusions: The majority of oral antibiotic course durations follow guidelines. Costs of antibiotic therapy were lower for shorter courses and those utilizing generic medications; the cost-effectiveness of these modifications has not been investigated.

UR - http://www.scopus.com/inward/record.url?scp=85046630865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046630865&partnerID=8YFLogxK

U2 - 10.1080/09546634.2018.1468069

DO - 10.1080/09546634.2018.1468069

M3 - Article

C2 - 29676194

AN - SCOPUS:85046630865

VL - 30

SP - 63

EP - 67

JO - Journal of Dermatological Treatment

JF - Journal of Dermatological Treatment

SN - 0954-6634

IS - 1

ER -